Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial-Reference-Cited by-同舟云学术

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

Published:2022-09 Issue:9 Volume:22 Page:1329-1342
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Samuels Aaron M,Ansong Daniel,Kariuki Simon K,Adjei Samuel,Bollaerts Anne,Ockenhouse Christian,Westercamp Nelli,Lee Cynthia K,Schuerman Lode,Bii Dennis K,Osei-Tutu Lawrence,Oneko Martina,Lievens Marc,Attobrah Sarfo Maame Anima,Atieno Cecilia,Morelle Danielle,Bakari Ashura,Sang Tony,Jongert Erik,Kotoh-Mortty Maame Fremah,Otieno Kephas,Roman François,Buabeng Patrick Boakye Yiadom,Ntiamoah Yaw,Ofori-Anyinam Opokua,Agbenyega Tsiri,Sambian David,Agordo Dornudo Albert,Nana Badu Lydia,Akoi Kwame,Antwi Evans,Onoka Kelvin,K'Orimba Kevin,Ndaya Oloo Paul,Leakey Elizabeth,Gvozdenovic Emilia,Cravcenco Cristina,Vandoolaeghe Pascale,Vekemans Johan,Ivinson Karen

Funder

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference23 articles.

1. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children;Agnandji;N Engl J Med,2011

2. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial;Lancet,2015

3. Malaria vaccine approval: a step change for global health;Lancet,2021

4. A phase IIa controlled human malaria infection and immunogenicity study of RTS,S/AS01E and RTS,S/AS01B delayed fractional dose regimens in malaria-naive adults;Moon;J Infect Dis,2020

5. Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: a phase 2a controlled human malaria parasite infection and immunogenicity study;Regules;J Infect Dis,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial;The Lancet Infectious Diseases;2024-09

2. Asymptomatic parasitemia and RTS,S vaccine efficacy;The Lancet Infectious Diseases;2024-09

3. Gaps in the implementation of RTS, S malaria vaccine contributing to the low uptake in an endemic area of western Kenya;2024-08-09

4. Adjuvant system AS01: from mode of action to effective vaccines;Expert Review of Vaccines;2024-08-05

5. Malaria vaccines: a new era of prevention and control;Nature Reviews Microbiology;2024-07-18